Brooksbank, Jeremy A.
Faulkenberg, Kathleen D.
Tang, W. H. Wilson
Martyn, Trejeeve http://orcid.org/0000-0002-6754-3670
Funding for this research was provided by:
National Institute for Health Care Management Foundation (R01HL146754)
Article History
Accepted: 22 February 2023
First Online: 5 April 2023
Compliance with Ethical Standards
:
: Dr. Tang is partially supported by a grant from the National Institutes of Health (R01HL146754) and is a consultant for Sequana Medical, Cardiol Therapeutics, Genomics plc, Zehna Therapeutics, Renovacor, WhiteSwell, Kiniksa, CardiaTec Biosciences, Applied Therapeutics, and Boston Scientific and has received honorarium from Springer Nature and the American Board of Internal Medicine. Dr. Tang is also on the medical advisory board for the Myocarditis Foundation. Dr. Martyn is an advisor to Recora health and Cleveland Clinic American Well Joint Venture and receives research support from Ionis therapeutics. He also receives consulting fees from Fire1. Dr. Brooksbank declares that he has no conflict of interest. Dr. Faulkenberg declares that she has no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
Free to read: This content has been made available to all.